233 related articles for article (PubMed ID: 9255157)
21. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms.
Even-Sapir E; Keidar Z; Sachs J; Engel A; Bettman L; Gaitini D; Guralnik L; Werbin N; Iosilevsky G; Israel O
J Nucl Med; 2001 Jul; 42(7):998-1004. PubMed ID: 11438618
[TBL] [Abstract][Full Text] [Related]
22. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
[TBL] [Abstract][Full Text] [Related]
23. 111In-Pentetreotide SPECT/CT in Pulmonary Carcinoid.
Chiaravalloti A; Spanu A; Danieli R; Dore F; Piras B; Falchi A; Tavolozza M; Madeddu G; Schillaci O
Anticancer Res; 2015 Jul; 35(7):4265-70. PubMed ID: 26124388
[TBL] [Abstract][Full Text] [Related]
24. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
[TBL] [Abstract][Full Text] [Related]
25. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
26. Precise fusion of MRI and dual energy 111In WBC/99mTc HDP SPECT/CT in the diabetic foot using companion CT: an example of SPECT/MRI imaging.
Knešaurek K; Kolker D; Vatti S; Heiba S
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):129-35. PubMed ID: 25854555
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of mandibular invasion by head and neck cancers using 99mTc-methylene diphosphonate or 99mTc-hydroxymethylene diphosphonate and 201Tl chloride dual isotope single photon emission computed tomography.
Suzuki A; Togawa T; Kuyama J; Nakahara T; Kinoshita F; Takenouchi T; Harada H; Omura K
Ann Nucl Med; 2004 Jul; 18(5):399-408. PubMed ID: 15462402
[TBL] [Abstract][Full Text] [Related]
28. Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours.
Castaldi P; Rufini V; Treglia G; Bruno I; Perotti G; Stifano G; Barbaro B; Giordano A
Radiol Med; 2008 Oct; 113(7):1056-67. PubMed ID: 18797822
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Kwekkeboom DJ; Lamberts SW; Habbema JD; Krenning EP
J Nucl Med; 1996 Jun; 37(6):886-92. PubMed ID: 8683305
[TBL] [Abstract][Full Text] [Related]
30. Dual-isotope SPECT using (99m)Tc-hydroxymethylene diphosphonate and (201)Tl-chloride to assess mandibular invasion by intraoral squamous cell carcinoma.
Yamamoto Y; Nishiyama Y; Satoh K; Ohbayashi Y; Iwasaki A; Miyabe K; Ohkawa M
J Nucl Med; 2002 Nov; 43(11):1464-8. PubMed ID: 12411549
[TBL] [Abstract][Full Text] [Related]
31. Additional diagnostic value of hybrid SPECT-CT systems imaging in patients with differentiated thyroid cancer.
Toubert ME; Vija L; Vercellino L; Banayan S; Faugeron I; Berenger N; Meas T; Marzola MC; Chondrogiannis S; Hindié E; Rubello D
Am J Clin Oncol; 2014 Jun; 37(3):305-13. PubMed ID: 22781388
[TBL] [Abstract][Full Text] [Related]
32. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours.
Krausz Y; Keidar Z; Kogan I; Even-Sapir E; Bar-Shalom R; Engel A; Rubinstein R; Sachs J; Bocher M; Agranovicz S; Chisin R; Israel O
Clin Endocrinol (Oxf); 2003 Nov; 59(5):565-73. PubMed ID: 14616879
[TBL] [Abstract][Full Text] [Related]
33. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
Lebtahi R; Cadiot G; Delahaye N; Genin R; Daou D; Peker MC; Chosidow D; Faraggi M; Mignon M; Le Guludec D
J Nucl Med; 1999 Oct; 40(10):1602-8. PubMed ID: 10520698
[TBL] [Abstract][Full Text] [Related]
34. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours.
Amthauer H; Denecke T; Rohlfing T; Ruf J; Böhmig M; Gutberlet M; Plöckinger U; Felix R; Lemke AJ
Eur Radiol; 2005 Jul; 15(7):1456-62. PubMed ID: 15627182
[TBL] [Abstract][Full Text] [Related]
35. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
[TBL] [Abstract][Full Text] [Related]
36. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
[TBL] [Abstract][Full Text] [Related]
37. [Thoracic SPECT using (111 In-DTPA-D-Phe1)-octreotide in bronchial carcinoid syndrome].
Banzo J; Sebastián A; Prats E; Freile E; García F; Costán J; Razola P; Tomás A; Cegoñino J; Abós MD
Rev Esp Med Nucl; 1998; 17(1):45-8. PubMed ID: 9609844
[TBL] [Abstract][Full Text] [Related]
38. Localization and identification of parapharyngeal metastases from differentiated thyroid carcinoma by 131I-SPECT/CT.
Qiu ZL; Xu YH; Song HJ; Luo QY
Head Neck; 2011 Feb; 33(2):171-7. PubMed ID: 20848436
[TBL] [Abstract][Full Text] [Related]
39. SPECT/CT in musculoskeletal infections.
Thang SP; Tong AK; Lam WW; Ng DC
Semin Musculoskelet Radiol; 2014 Apr; 18(2):194-202. PubMed ID: 24715450
[TBL] [Abstract][Full Text] [Related]
40. Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis.
Ingui CJ; Shah NP; Oates ME
J Comput Assist Tomogr; 2007; 31(3):375-80. PubMed ID: 17538282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
